Morgan Stanley Call 23 UEN 20.12..../ DE000ME6NMK3 /
30.05.2024 8:32:43 | Изменение-0.010 | Бид30.05.2024 | Предложение30.05.2024 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
0.380EUR | -2.56% | 0.380 Величина цены спроса: 5,000 |
- Величина цены предложения: - |
UBISOFT ENTMT IN.EO-... | 23.00 EUR | 20.12.2024 | Call |
GlobeNewswire
8:35
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
8:30
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
8:30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
8:30
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
GlobeNewswire
8:30
Combined General Meeting of June 20, 2024 - Availability of the preparatory documents
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница